Major lupus drug trial halted before starting
Disease control
Terminated
This was a large, late-stage study designed to test whether an investigational drug called telitacicept could better control disease activity in people with moderate-to-severe lupus compared to a placebo. The drug works by targeting parts of the immune system thought to drive the…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC